Cary Street Partners Investment Advisory LLC Catalent, Inc. Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $31,337 - $35,591	709 Added 1162.3%	770 $35,000
Q2 2023 Aug 10, 2023	SELL	$31.86 - $67.26 $2,389 - $5,044	-75 Reduced 55.15%	61 $2,000
Q1 2023 May 12, 2023	BUY	$45.44 - $74.26 $908 - $1,485	20 Added 17.24%	136 $8,000
Q4 2022 Feb 14, 2023	BUY	$41.39 - $81.0 $4,801 - $9,396	116 New	116 $5,000

Others Institutions Holding CTLT

# of Institutions

511

Shares Held

149M

Call Options Held

575K

Put Options Held

2.03M

Vanguard Group Inc Valley Forge, PA

20.2M
Shares

$1.28 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

15.4M
Shares

$975 Million
0.02% of portfolio
State Street Corp Boston, MA

7.45M
Shares

$473 Million
0.02% of portfolio
Capital World Investors Los Angeles, CA

6.4M
Shares

$406 Million
0.06% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

4.52M
Shares

$287 Million
0.14% of portfolio

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account